Showing results (281-290 of 315) with videos related to
Sort By:
Pageof 32
Journal of Molecular Medicine (Berlin, Germany)|April 30, 2013
Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behçet's disease susceptibilityJoana M Xavier, Tiago Krug, Fereydoun Davatchi, et al.International Journal of Rheumatic Diseases|April 9, 2014
IL10 low-frequency variants in Behçet's disease patientsMafalda Matos, Joana M Xavier, Patrícia Abrantes, et al.Psychological Medicine|August 31, 2016
The cross-national epidemiology of DSM-IV intermittent explosive disorderK M Scott, C C W Lim, I Hwang, et al.Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|September 14, 2013
A combined enrichment/polymerase chain reaction based method for the routine screening of Streptococcus agalactiae in pregnant womenF M Munari, F De-Paris, G D Salton, et al.Clinical Rheumatology|May 25, 2020
Cachexia in patients with rheumatoid arthritis: a cohort studyRafaela Ce Santo, Jordana Ms Silva, Priscila S Lora, et al.Journal of Personalized Medicine|September 28, 2021
Metabolomic Biomarker Candidates for Skeletal Muscle Loss in the Collagen-Induced Arthritis (CIA) ModelPaulo V G Alabarse, Jordana M S Silva, Rafaela C E Santo, et al.Menopause (New York, N.Y.)|December 16, 2025
Pharmacokinetic analysis of 25 mg estradiol subcutaneous bioabsorbable implant in postmenopausal women (CLARA STUDY)André Malavasi, Camilla M Ribeiro, Leandro B Agati, et al.Human Genetics|January 29, 2010
Kalirin: a novel genetic risk factor for ischemic strokeTiago Krug, Helena Manso, Liliana Gouveia, et al.Epidemiology and Psychiatric Sciences|September 24, 2013
A comparative analysis of role attainment and impairment in binge-eating disorder and bulimia nervosa: results from the WHO World Mental Health SurveysR C Kessler, V Shahly, J I Hudson, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 20, 2020
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III TrialHermine I Brunner, Nicolino Ruperto, Zbigniew Zuber, et al.Pageof 32